Following a proposal from the FDA and its members, I am pleased to announce a reduction in the cost of classifying content-identical versions of 3D theatrical features (whether DCP or IMAX). From Tuesday 4 January 2011, subject to the film distributor receiving classification for the 3D DCP or 3D IMAX version first, the content-identical 2D version will be processed as a 3D/2D technical comparisonÂ and attain the same category. The charge will be 50% of the standard tariff + VAT.
Please note that the reduced rate will only apply if the 3D DCP or 3D IMAX version is submitted and approved first.
Should the 2D version be approved first, the 3D version will be examined and charged at the standard tariff because the enhanced visual experience retains the potential to receive a more restrictive classification. A further reduction is on offer for a simultaneous submission of a DCP file containing the 3D/2D versions. In this case the 2D classification will receive the minimum film charge of £100 + VAT. This initiative entails a risk that the subsequent works may be overclassified. So, to give film distributors maximum flexibility, particularly in those borderline cases where, say, the 2D work might be acceptable at a lower category than the 3D/IMAX work, the option to have the 2D work classified separately remains. In this case the standard tariff will apply.
These cost-savings further underlines the BBFC's commitment to its customers in providing the most efficient service.